The study investigates how blood lipids and statins affect kidney function and overall mortality in patients with diabetic nephropathy (DN) by analyzing data from various medical databases.
It finds that higher levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are linked to a greater risk of progressing to end-stage renal disease (ESRD) in these patients.
Additionally, the use of statins is associated with lower urinary albumin excretion (UAE) and reduced risk of ESRD, suggesting their potential protective effects on kidney health in DN patients.